Clinical Trial

Safety Evaluation of β-Arbutin in Healthy Human Subjects

Study Description

Safety Evaluation of β-arbutin in Healthy Human Subjects

The purpose of this study is to determine the safety of synthetic beta-arbutin, a dietary supplement that aids in the prevention and treatment of calcium oxalate kidney stones, when administered to healthy human subjects.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Dietary Supplement - Beta-arbutin

Beta-arbutin capsules

Placebo

Placebo capsules containing non-medicinal ingredients

Additional Information

Official Study Title

Safety Evaluation of β-arbutin in Healthy Human Subjects

Clinical Trial ID

NCT03868748

ParticipAid ID

epYnma